Search research articles
Contact Us
Filters
Showing results (271-280 of 315) with videos related to
Page
of 32
Sort By:
Plos One
|
March 7, 2014
Radiologically isolated syndrome: 5-year risk for an initial clinical event
Darin T Okuda, Aksel Siva, Orhun Kantarci, et al.
Annals of Clinical and Translational Neurology
|
January 25, 2025
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy
Ermelinda De Meo, Emilio Portaccio, Rosa Cortese, et al.
Neurology
|
January 21, 2021
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Giacomo Boffa, Luca Massacesi, Matilde Inglese, et al.
Immunity
|
October 3, 2025
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis
Mehdi Benamar, Paola Contini, Klaus Schmitz-Abe, et al.
Bone Marrow Transplantation
|
September 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
Raffaella Greco, Riccardo Saccardi, Marta Ponzano, et al.
European Journal of Neurology
|
September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosis
Irene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Multiple Sclerosis and Related Disorders
|
February 5, 2026
First demyelinating attack in children: A twelve year single center cohort
Alessandro Santagostino Barbone, Thea Giacomini, Silvia Casabona, et al.
International Journal of Medical Informatics
|
June 10, 2026
Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey
Luigi Lavorgna, Giuseppina Miele, Marta Ponzano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 15, 2024
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study
Caterina Lapucci, Jessica Frau, Eleonora Cocco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis
Emilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 315) with videos related to
Sort By:
Page
of 32
Plos One
|
March 7, 2014
Radiologically isolated syndrome: 5-year risk for an initial clinical event
Darin T Okuda, Aksel Siva, Orhun Kantarci, et al.
Annals of Clinical and Translational Neurology
|
January 25, 2025
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy
Ermelinda De Meo, Emilio Portaccio, Rosa Cortese, et al.
Neurology
|
January 21, 2021
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Giacomo Boffa, Luca Massacesi, Matilde Inglese, et al.
Immunity
|
October 3, 2025
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis
Mehdi Benamar, Paola Contini, Klaus Schmitz-Abe, et al.
Bone Marrow Transplantation
|
September 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
Raffaella Greco, Riccardo Saccardi, Marta Ponzano, et al.
European Journal of Neurology
|
September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosis
Irene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Multiple Sclerosis and Related Disorders
|
February 5, 2026
First demyelinating attack in children: A twelve year single center cohort
Alessandro Santagostino Barbone, Thea Giacomini, Silvia Casabona, et al.
International Journal of Medical Informatics
|
June 10, 2026
Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey
Luigi Lavorgna, Giuseppina Miele, Marta Ponzano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 15, 2024
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study
Caterina Lapucci, Jessica Frau, Eleonora Cocco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis
Emilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Page
of 32